Combining COVID-19 BA4/5 and Influenza mRNA

“Recently, both Pfizer and Moderna announced they were developing a combination injection utilizing mRNA coding for the BA4/BA5 Omicron subvariant and new mRNA coding for antigens contained in the influenza virus.[i] Because the COVID-19 component is under Emergency Use Authorization plus questionable unorthodox licensure meant to provide the legal basis for a system of vast mandates, limited animal studies plus no completed human trial data to date, that component should be off the table from the start.”

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

%d bloggers like this: